EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 29 filers reported holding EVOKE PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,000 | -91.7% | 3,828 | -79.5% | 0.00% | – |
Q3 2021 | $24,000 | -27.3% | 18,655 | -23.4% | 0.00% | – |
Q2 2021 | $33,000 | +13.8% | 24,355 | +51.3% | 0.00% | – |
Q1 2021 | $29,000 | -67.4% | 16,101 | -53.3% | 0.00% | – |
Q4 2020 | $89,000 | +196.7% | 34,500 | +430.8% | 0.00% | – |
Q3 2020 | $30,000 | – | 6,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 242,500 | $1,962,000 | 1.69% |
SOPHROSYNE CAPITAL LLC | 49,000 | $397,000 | 0.40% |
LMR Partners LLP | 23,882 | $187,000 | 0.02% |
GEODE CAPITAL MANAGEMENT, LLC | 10,276 | $80,000 | 0.00% |
BlackRock Investment Management, LLC | 489 | $4,000 | 0.00% |
MORGAN STANLEY | 500 | $4,000 | 0.00% |
Tower Research Capital LLC (TRC) | 84 | $1,000 | 0.00% |
VANGUARD GROUP INC | 48,394 | $378,000 | 0.00% |
UBS AG | 727 | $6,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 33,500 | $271,000 | 0.00% |